BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2462284)

  • 1. [Hemodilution in peripheral arterial occlusive disease].
    Becsi C; Wehofer D; Weidinger P
    Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treadmill ergometer multistage test: a new alternative in diagnosis and therapeutic control of peripheral arterial occlusive disease].
    Weidinger P; Bachl N; Liebenberger S
    Vasa Suppl; 1988; 26():48-50. PubMed ID: 2462285
    [No Abstract]   [Full Text] [Related]  

  • 7. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
    Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
    Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
    Kiesewetter H; Jung F; Birk A; Spitzer S
    Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorheologic therapy in peripheral arterial occlusive disease].
    Kiesewetter H; Jung F
    Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current therapy of peripheral arterial occlusive diseases in the aged].
    Schütz RM
    Z Gerontol; 1992; 25(2):101-4. PubMed ID: 1609537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does improved circulation also mean improved tissue supply?].
    Ehrly AM
    Fortschr Med; 1986 Jul; 104(25):492-4. PubMed ID: 3744256
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidural electrostimulation of the spinal cord for therapy of Fontaine stage III peripheral arterial occlusive disease].
    Jünger M; Hahn M; Hoffmann F; Fenchel G; Schulze M
    Vasa Suppl; 1991; 32():402-5. PubMed ID: 1771544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Smoking cessation using alternative nicotine administration in patients with peripheral arterial occlusive disease. Effects on peripheral circulation, hematologic parameters and lipoprotein status].
    Diehm C; Emmerich M; Schork M; Schöckel KH
    Vasa Suppl; 1990; 29():1-53. PubMed ID: 2377961
    [No Abstract]   [Full Text] [Related]  

  • 17. Isovolemic hemodilution: a therapeutical intervention for improving microcirculation.
    Rudofsky G
    Int Angiol; 1986; 5(3):151-4. PubMed ID: 3559316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rotation angioplasty--a new technic for reopening chronic arterial occlusions].
    Vallbracht C; Prignitz I; Liermann D; Beinborn W; Süss B; Awiszus H; Bamberg W; Landgraf H; Roth FJ; Kollath J
    Vasa Suppl; 1988; 23():161-7. PubMed ID: 2974636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
    Müller-Bühl U; Comberg HU; Diehm C; Allenberg J; Mörl H
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):241-3. PubMed ID: 6178019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early and late results of conservative therapy in patients with peripheral arterial circulatory disorders of clinical stage IV].
    Rieger H; Reinecke B; Levy H
    Vasa Suppl; 1984; 12():124-32. PubMed ID: 6592891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.